Act Capital Management, LLC Sio Gene Therapies Inc. Transaction History

Act Capital Management, LLC

  • $72.5 Million
  • Q3 2022

A detailed history of Act Capital Management, LLC transactions in Sio Gene Therapies Inc. stock. As of the latest transaction made, Act Capital Management, LLC holds 146,500 shares of SIOX stock, worth $0. This represents 0.06% of its overall portfolio holdings.

Number of Shares
146,500
Previous 146,500 -0.0%
Holding current value
$0
Previous $53,000 22.64%
% of portfolio
0.06%
Previous 0.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022
SELL
$0.55 - $1.47 $21,175 - $56,595
-38,500 Reduced 20.81%
146,500 $98,000
Q2 2021

Aug 16, 2021
BUY
$2.07 - $2.89 $382,949 - $534,650
185,000 New
185,000 $506,000

Others Institutions Holding SIOX

# of Institutions
2
Shares Held
147K
Call Options Held
0
Put Options Held
0
View Full List

About Sio Gene Therapies Inc.

SIOX Quotes by TradingView
  • Ticker SIOX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,975,200
  • Description
  • Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...
More about SIOX
Track This Portfolio

Track Act Capital Management, LLC Portfolio

Follow Act Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Act Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Act Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email